Erika Sloan

She supports companies in the biopharma and healthcare diagnostics spaces from early-stage development through product launch and beyond. She leads projects that inform life sciences commercial strategy by integrating insights across different data sources including claims analytics, primary research, and secondary data, with an emphasis on strategic market research. Erika has extensive experience in global qualitative and quantitative research engagements, particularly buying process and patient journey analyses, customer segmentation and targeting, and opportunity assessments. Although her work spans a broad range of therapeutic areas, her particular fields of specialization are oncology and rare diseases.